NBY  Novabay Pharmaceuticals Inc.

Exchange

AMEX

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

47.7M

Vuru Grade

30.66/100

Current Price

$1.05
+0.05 (+5.00%)

Growth Price

$0.05
Overvalued by 95.71%

Company Metrics

  • 0 P/E
  • 13.06 P/S
  • 5.24 P/B
  • -0.42 EPS
  • -2,638.06% Cash ROIC
  • 4.98 Cash Ratio
  • 0 / 0% Dividend
  • 136,600.00 Avg. Vol.
  • 25.77M Shares
  • 47.7M Market Cap.

Company Description

NovaBay Pharmaceuticals Inc., a clinical stage biotechnology company, engages in developing proprietary and patented topical Aganocide compounds for the treatment and prevention of various infections without causing bacterial resistance. Its Aganocide compounds are synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white bloo...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.